Bioavailable constituents/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX2 activity ex vivo and IL-1beta-induced PGE2 production in human chondrocytes in vitro
2008

Pomegranate Extract and Its Effects on Inflammation

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Meenakshi Shukla, Kalpana Gupta, Zafar Rasheed, Khursheed A Khan, Tariq M Haqqi

Primary Institution: Case Western Reserve University

Hypothesis

Does oral consumption of pomegranate fruit extract inhibit COX-2 activity and IL-1β-induced PGE2 production in human chondrocytes?

Conclusion

Pomegranate fruit extract constituents become bioavailable after ingestion and significantly inhibit COX-2 activity and the production of inflammatory mediators in chondrocytes.

Supporting Evidence

  • Plasma samples after pomegranate extract ingestion inhibited IL-1β-induced PGE2 production in chondrocytes.
  • COX-2 enzyme activity was significantly inhibited by plasma samples obtained after pomegranate extract supplementation.
  • Bioavailable constituents of pomegranate extract were detected in plasma after oral ingestion.

Takeaway

Eating pomegranate can help reduce inflammation in your body by stopping certain chemicals that cause swelling.

Methodology

Rabbits were given pomegranate fruit extract, and their plasma was analyzed for its effects on COX enzyme activity and inflammatory mediator production in chondrocytes.

Limitations

The study was conducted on rabbits, and results may not directly translate to humans.

Participant Demographics

6 New Zealand white rabbits, male, 1 year old, average weight 3.7 kg.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1476-9255-5-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication